Pricing and Reimbursement

The Centers for Medicare & Medicaid Services (CMS) has officially entered into agreements with manufacturers of 15 prescription drugs selected for the second cycle...

In a significant shift aimed at enhancing workplace health, Finland restructured its occupational health services (OHS) reimbursement system at the start of 2020. This...

On March 11, 2025, Germany's Joint Federal Committee announced a significant update to the national pharmaceutical guidelines by including Nitisinon in Festbetragsgruppe 1, Stage...

Recent research highlights a significant disparity in the cost of generic medications in Korea compared to other affluent countries. The study meticulously analyzes prices...

President Donald J. Trump has taken decisive action to enhance transparency in the American healthcare system by issuing a new executive order. This move...

European health authorities are grappling with the financial implications of gene therapies, which promise significant advancements in treating genetic diseases but come with high...

Croatia is exploring innovative pricing strategies for oncology medications to alleviate the financial strain on its healthcare system. As pharmaceutical expenses soar globally, the...

The European Union has officially published the Critical Medicines Act, marking a significant advancement towards enhancing Europe's autonomy in pharmaceutical supply. This legislation aims...

Germany has taken significant steps to regulate the cost of digital health applications, introducing maximum reimbursement prices to address escalating expenses within its statutory...

Pharmac is inviting public input on its plan to finance Ryzodeg, a novel insulin blend, starting May 1, 2025. This initiative aims to enhance...

The escalating prevalence of rare diseases worldwide has led to a significant increase in the costs associated with orphan drugs, placing immense pressure on...

Germany takes a decisive step in regulating the costs of digital health applications by introducing maximum reimbursement prices. This move aims to prevent skyrocketing...

As healthcare options expand in China, middle-aged and elderly individuals increasingly opt for hospitals offering higher health insurance reimbursement rates. This trend underscores the...

China's evolving health insurance reimbursement rates are significantly influencing the hospital selection behavior of its middle-aged and elderly populations, reshaping how medical resources are...

The National Institute for Health and Health Technology Assessment (NIHO) in Slovakia has recommended against including Ketoanalog, a dietary supplement designed for patients with...